Mounjaro®
Starting from £179.99/mo
Start journey Learn morePeople across Wales are asking the same question: can they access weight loss injections without joining a lengthy NHS waiting list? The short answer is yes, through a private route. Two medicines are currently licensed in the UK for weight management: tirzepatide (Mounjaro) and semaglutide (Wegovy). Both are prescription-only medicines, which means a qualified prescriber must assess your suitability before any treatment begins. Wherever you live in Wales, that clinical step is non-negotiable.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Access through the NHS in Wales follows a different commissioning pathway from England. In England, NICE technology appraisals such as TA1026 for tirzepatide drive phased NHS rollout through GP practices and specialist services. In Wales, medicines commissioning decisions are made by the All Wales Medicines Strategy Group (AWMSG) and delivered through Local Health Boards, so eligibility thresholds and waiting times can differ significantly by area.
In practice this means two things. First, even if you meet the criteria on paper, your Local Health Board may have a waiting list that stretches months. Second, the specialist tier required for NHS semaglutide access under TA875 is not evenly available across every part of Wales. Rural communities in Powys or Ceredigion often face longer waits than those in Cardiff or Swansea.
If the NHS route does not suit your timeline, a regulated online pharmacy can offer private treatment, and our guide to weight loss injectables covers the options available without a postcode restriction. You can read more about how private and NHS routes compare on our weight loss treatment overview.
The licensed eligibility criteria for both medicines are set out in their Summaries of Product Characteristics. In general, both are approved for adults with a BMI of 30 or above, or a BMI of 27 or above alongside at least one weight-related health condition such as high blood pressure, high cholesterol, obstructive sleep apnoea, prediabetes or type 2 diabetes. For some South Asian, Chinese, Middle Eastern, Black African or African-Caribbean backgrounds, NICE guidance applies thresholds 2.5 kg/m² lower.
A BMI number alone does not decide the outcome. A prescriber looks at your full picture: other medicines you take, relevant medical history, any contraindications such as a personal history of medullary thyroid carcinoma, and whether the timing is right. Pregnancy, breastfeeding and trying to conceive are all situations where these medicines are not recommended. Neither is licensed for under-18s.
The NHS BMI calculator at nhs.uk is a useful starting point, but treat it as one piece of information rather than a decision. Our FAQs cover common eligibility questions if you want to read further before booking.
Tirzepatide activates two receptors involved in appetite and blood-sugar regulation: GIP and GLP-1. Semaglutide works on GLP-1 alone. Both slow gastric emptying and reduce hunger signals, which tends to make eating less effortful rather than relying on willpower. In the SURMOUNT-1 clinical trial, participants taking the highest tirzepatide dose lost around 20% of their body weight on average over 72 weeks. The STEP 1 trial reported around 15% average loss with semaglutide 2.4mg over 68 weeks, as detailed in the original paper in the New England Journal of Medicine.
Treatment always starts low. Tirzepatide begins at 2.5mg, and semaglutide at 0.25mg. The prescriber increases the dose gradually over several months, watching how your body responds before moving up. Both come as pre-filled pens that you inject once a week, typically into the abdomen, thigh or upper arm. If you are considering which weight loss injection might suit you, that is a question worth raising at consultation: our prescribers hear it often, and the technique is straightforward for most people once walked through it.
For a broader look at how these medicines compare with each other, the guide to weight loss injections goes through the evidence side by side.
The only legal route is a prescription issued after a clinical assessment. A regulated online pharmacy can provide this without you having to travel anywhere, and if you are wondering where you can buy weight loss injections safely and legally, that guide walks through what to look for in a legitimate provider. At nume, a GPhC-registered Independent Prescriber reads every consultation personally; no automated system approves treatment. You will be asked to verify your identity with a photo ID, confirm your weight on a live video call, and disclose any relevant medicines you already take. If you are transferring from another provider, you will need evidence of your current dose before a prescriber will continue or increase it.
Order by 12pm Monday to Friday and, if the prescriber approves treatment that day, your medication is dispatched and delivered free the next working day by DPD in plain packaging. If payday falls on a Friday and you want to start the same week, that timing works. Details of what each step involves are on the GP and prescriber access page.
Before ordering from any online pharmacy, look it up on the GPhC pharmacy register. Red flags include sellers who offer these medicines without requesting a prescriber consultation, or who advertise discount codes. The MHRA has warned publicly about counterfeit pens sold online; some have contained entirely different substances. Report anything suspicious through the Yellow Card scheme.
For cost context across providers, our overview of the 3 weight loss injections most commonly prescribed privately explains what legitimate pricing usually includes and why headline figures can be misleading. When you are ready to take the next step, you can start a free consultation with our clinical team.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.